Who is sponsoring NCT04025996?

NCT04025996 is sponsored by National Heart Centre Singapore.

What drugs are being tested in NCT04025996?

Interventions in NCT04025996: Cardiac Assessments and Eye Assessments.

What condition does NCT04025996 study?

NCT04025996 studies Retinopathy, Diabetic, Diastolic Dysfunction, Microalbuminuria.

Is NCT04025996 still recruiting?

NCT04025996 is currently status unknown. Last updated 3 February 2021.

Last reviewed 2021-02-03 · How we verify

NCT04025996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus

Status unknown Last updated 3 February 2021

What this trial tests

trial testing Cardiac Assessments and Eye Assessments in Retinopathy, Diabetic in 60 participants. Status unknown.

Timeline

20 February 2018

Primary endpoint
31 May 2021

31 May 2021

Quick facts

Lead sponsor	National Heart Centre Singapore
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	60
Start date	20 February 2018
Primary completion	31 May 2021
Estimated completion	31 May 2021
Sites	1 location across Singapore

Drugs / interventions tested

Cardiac Assessments and Eye Assessments

Conditions studied

Retinopathy, Diabetic — all drugs for Retinopathy, Diabetic →
Diastolic Dysfunction — all drugs for Diastolic Dysfunction →
Microalbuminuria — all drugs for Microalbuminuria →

Sponsor

National Heart Centre Singapore — full company profile →

Who can join

Adults 21 to 120, any sex, with Retinopathy, Diabetic or Diastolic Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retinopathy may be associated with diastolic dysfunction and/or coronary flow reserve in the heart, and albuminuria in diabetic patients. The objective of this study is to examine the cross-sectional relationships of retinopathy with indices of left ventricular diastolic function, coronary flow reserve and urinary albumin excretion, among diabetic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Retinopathy, Diabetic

Currently open trials in the same condition.

NCT06376240 — The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes · NA · active not recruiting

Other National Heart Centre Singapore trials

Trials by the same sponsor.

NCT06645691 — Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body · Phase 2 · recruiting
NCT05912218 — REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD · Phase 2 · active not recruiting
NCT05946174 — Tackling Disruptions to Frailty Interventions: Developing Personalized Interventions Targeted for Older Persons With Car · NA · recruiting
NCT05775484 — Exercise to Slow Cardiovascular Ageing Progression · recruiting
NCT07376993 — Pulse Signal Acquisition in Patients With Heart Failure · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04025996 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Heart Centre Singapore
Last refreshed: 3 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04025996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing